3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Dermatologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Lung Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Non-small-cell Lung Cancer With Somatic EGFR Mutations
2
Neoplasms
2
Neoplasm Metastasis
2
Head and Neck Neoplasms
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Thrombocytosis
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
NSCLC Harboring NRG1 Fusion
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mouth Neoplasms
1
Meningeal Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Interventions
Biopsy
4
Surgical Procedures, Operative
3
Cisplatin
3
Cetuximab
3
Radiotherapy
2
Fluorouracil
2
Cyclophosphamide
2
Celecoxib
2
tozuleristide
1
temsirolimus
1
antineoplaston AS 2-1
1
antineoplaston A10
1
advexin
1
Valproic Acid
1
Thalidomide
1
Sirolimus
1
Observation
1
Metformin
1
Immunohistochemistry
1
Immunoglobulin G
1
Fluorescent Antibody Technique
1
Flow Cytometry
1
Fenretinide
1
Everolimus
1
Etoposide
1
Electroacupuncture
1
Docetaxel
1
Disulfides
1
Dihematoporphyrin Ether
1
Diagnosis, Oral
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Mouth Neoplasms
×
Afatinib
×
Clear all
NCT06897735
2026-06-03
EDDIS-a1
Petrov, Andrey
Phase 1
Terminated
4 enrolled